Visit our booth to meet the Associate Editor for Pediatrics, Endocrinology and Diabetes of JAMA Network Open, Amy Sanghavi Shah, MD, MS. Saturday June 24, 12:30-1:00 PM – Booth 1023 Watch the JAMA Network Video Learn more about JAMA and other journals in this short video. Play No...
These studies were presented during the symposium entitled “Retatrutide (LY3437943), a Novel GIP/GLP-1/Glucagon Receptor Triagonist—Obesity, NAFLD, and T2D Phase 2 Trial Results,” a late-breaking symp...
Starts: 1/28/2025 | Expires: 1/28/2027 The Inpatient Diabetes Certificate is a comprehensive program that prepares healthcare professionals to effectively manage diabetes and hyperglycemia in hospitalized patients. $295 | Informed Members - $235 | Engaged Members - $175 ...
I’ve done a few things to raise some money for the American Diabetes Association, but nothing really major. I had a dream in the second week of January 2018 that I was raising money riding my motorcycle all over the country and that I raised $90,000.00. I thought this was a great ...
More than half of US adults—approximately 137 million—are candidates for semaglutide based on diabetes, weight management, or cardiovascular prevention indications. Bumetanide Nasal Spray Equivalent to Oral, IV Forms for Heart Failure ByConnor Iapoce ...
The following diabetes program is available in conjunction with APhA2025 in Nashville, TN.This program is offered live and in-person. There is no virtual option for this session.You do not need to register for the APhA2025 Annual Meeting & Exposition to attend this additional offering but you...
BOSTON--(BUSINESS WIRE)-- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today presented data on all patients dosed in Parts A and B of its Phase 1/2 clinical trial of VX-880, an investigational stem cell-derived,...
Fellowship Director, Endocrinology, Diabetes and Metabolism and Diversity Director, Graduated Medical Education University of Arizona College of Medicine Phoenix, AZ Save The Date! AACE Annual Meeting 2025 will be held at the Hilton Orlando in Orlando, FL May 15 – 17, 2025. Register Now. ...
Vertex Presents Positive VX-880 Results From Ongoing Phase 1/2 Study in Type 1 Diabetes at the American Diabetes Association 83rd Scientific Sessions – All six patients treated with VX-880 engrafted islet cells, produced endogenous insulin (C-peptide) and had improved glycemic...
TBS may be especially useful in clinical situations, such as type 2 diabetes and primary hyperparathyroidism, where FRAX® without TBS may underestimate fracture risk. Q1.5.5. Inaccuracies in Bone Density Reports Inaccuracies in BMD readings can result from a variety of factors. These include the...